Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities
Net loss	$ (97.0)	$ (63.9)
(Loss) income from discontinued operations, net of tax	(7.8)	5.0
Loss from continuing operations, net of tax	(89.2)	(68.9)
Adjustments to reconcile net loss from continuing operations to net cash used by operating activities:
Depreciation	10.9	13.9
Amortization	4.8	6.0
Provision for doubtful accounts	14.1	17.4
Provision for obsolescence	6.4	7.7
Share-based compensation	2.4	0.6
Foreign exchange (gains) losses	(7.3)	0.5
Deferred income taxes	(2.5)	(1.6)
Other	(0.6)	0.3
Changes in assets and liabilities:
Accounts receivable	(20.6)	(18.4)
Inventories	(33.1)	(29.5)
Prepaid expenses and other	9.4	(21.6)
Accounts payable and accrued liabilities	(65.4)	(76.8)
Income and other taxes	3.2	0.8
Noncurrent assets and liabilities	(0.9)	0.7
Net cash used by operating activities of continuing operations	(168.4)	(168.9)
Cash Flows from Investing Activities
Capital expenditures	(13.6)	(13.8)
Disposal of assets	2.7	1.1
Net cash used by investing activities of continuing operations	(10.9)	(12.7)
Cash Flows from Financing Activities
Debt, net (maturities of three months or less)	86.8	7.9
Proceeds from debt	68.6	76.5
Repayment of debt	(18.9)	(12.6)
Repayment of debt to affiliates of Natura &Co	(10.7)	0.0
Repayment of debt by affiliates of Natura &Co	11.7	0.0
Settlement of derivative contracts	1.3	(4.8)
Net cash provided by financing activities of continuing operations	138.8	67.0
Net cash used by operating activities of discontinued operations	(5.6)	(1.5)
Net cash used by discontinued operations	(5.6)	(1.5)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash	3.1	(17.6)
Net decrease in cash and cash equivalents, and restricted cash	(43.0)	(133.7)
Cash and cash equivalents, and restricted cash at beginning of period	251.5	373.4
Cash and cash equivalents, and restricted cash at end of period	$ 208.5	$ 239.7